FDA PMA FDA Class 3 Approved 🇺🇸 United States

Stimulator, Spinal-Cord, Totally Implanted For Pain Relief

PMA: P030017 · Supplement: S389 · Decision Dec 10, 2025
Classifications
1
FEI Numbers
0
Registration Numbers
0

Research PMA P030017 in seconds

The Research Assistant summarizes PMA approval history, supplements and related safety signals — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Stimulator, Spinal-Cord, Totally Implanted For Pain Relief
Trade Name
WaveWriter Alpha™ Prime Spinal Cord Stimulation (SCS) Systems
PMA Number
P030017
Supplement Number
S389
Device Class
FDA Class 3
Product Code
LGW
Generic Name
Stimulator, spinal-cord, totally implanted for pain relief
Medical Specialty
Unknown
Advisory Committee
Neurology
Decision
Approved
Decision Code
APPR
Decision Date
December 10, 2025
Date Received
September 25, 2025
Supplement Type
Real-Time Process
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

approval for the extension of shelf-life from 6 months to 15 months for the Hydrogen Silsesquioxane material utilized in the insulation layer production of a component within the printed circuit board assembly of Implantable Pulse Generator (IPG) and of External Trial Stimulator (ETS) Kits in the WaveWriter Alpha™ Prime Spinal Cord Stimulation and Vercise™ Genus Deep Brain Stimulation Systems. The component, manufactured by a third-party supplier, is not patient-contacting and is fully encapsulated within the IPG and ETS.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LGW Stimulator, Spinal-Cord, Totally Implanted For Pain Relief